Margaret, a 68-year-old retired primary school teacher from Leeds, first noticed her heart “fluttering” while gardening in May 2024. Her GP ordered an ECG the same week, which showed atrial fibrillation (AF). The practice started her on a direct oral anticoagulant to reduce stroke risk and prescribed a beta-blocker for rate control. Then came the wait: a referral to a cardiologist for rhythm control and a fuller assessment. Six months later, she still had not been seen. “I was told it was routine and I’d get an appointment within 18 weeks,” she says. “But 18 weeks came and went. I rang the hospital; they said the waiting list was longer than expected.”

Margaret’s story is not unusual. In the UK, the median wait for a first cardiology outpatient appointment in the NHS is roughly 18 weeks for non-urgent referrals, and many patients with AF wait beyond that. Atrial fibrillation affects about 1.5 million people in the UK, and its prevalence is rising as the population ages. The condition increases the risk of stroke fivefold, and delays in specialist review mean that decisions about rhythm control—cardioversion or ablation—are postponed, leaving patients on rate-control drugs that may not fully relieve symptoms.

The Six-Month Wait for a Heart That Skips

AF is the most common sustained cardiac arrhythmia, and it accounts for a growing share of GP workload. The NHS target that 92% of patients should wait no more than 18 weeks for a first consultant-led appointment has been missed routinely for years. For cardiology, the picture is worse than the average: some trusts report that fewer than half of routine referrals are seen within 18 weeks. A survey by the Atrial Fibrillation Association found that one in five patients waited more than six months for a specialist appointment after their initial diagnosis.

The consequences of delay are not abstract. A 2023 study in the British Journal of General Practice estimated that each month a patient with untreated or suboptimally treated AF waits, their stroke risk rises by roughly 1–2 percentage points. While anticoagulation can be started in primary care, decisions about whether to pursue rhythm control—which may offer better symptom relief and potentially lower long-term stroke risk—require specialist input. “We have patients on warfarin or DOACs who are rate-controlled but still symptomatic,” says Dr. Helen Carter, a GP with a special interest in cardiology in Manchester. “They’re breathless climbing stairs, they can’t garden, they feel tired all the time. They need a cardiologist to discuss ablation or cardioversion, but the waiting list is brutal.”

For patients like Margaret, the wait also breeds anxiety. “Every time I felt a flutter, I wondered if this was the one that would cause a stroke,” she says. “I kept a diary of symptoms, but nobody looked at it for months.” The psychological burden is real: a 2024 survey by the British Heart Foundation found that nearly half of AF patients reported anxiety about their condition while waiting for specialist care.

Why Primary Care Can’t Catch Every Flip

AF is often paroxysmal—it comes and goes. A single 10-second ECG in a GP surgery may capture a normal rhythm if the patient is not in AF at that moment. Ambulatory monitors, such as 24-hour Holter monitors or longer-duration event recorders, are not universally available. A 2023 audit of GP practices in England found that only about one in three had direct access to ambulatory ECG monitoring without a cardiology referral. The rest rely on hospital-based services, which adds another layer of delay.

The typical GP consultation lasts ten minutes. In that window, a doctor must address the presenting complaint, review medications, check blood pressure, and perhaps order blood tests. A detailed history of palpitations—how often, how long, associated symptoms—can be squeezed in, but ambulatory monitoring often gets deferred. “If I suspect AF but the ECG is normal, I have to decide: do I refer for monitoring, or do I wait and see?” says Dr. James Okonkwo, a GP in Birmingham. “Referral pathways for ambulatory ECG are often unclear, and the waiting time for a hospital-issued monitor can be weeks. Meanwhile, the patient may have another episode.”

NICE guidelines recommend that anyone with suspected paroxysmal AF should have ambulatory ECG monitoring for at least 24 hours, and longer if symptoms are infrequent. But in practice, many GPs resort to using cheap, single-lead handheld ECG devices that patients can use at home. While these devices can capture episodes, they are not always integrated into the NHS record, and their sensitivity is lower than multi-lead monitoring. “We have a few KardiaMobile devices in our practice,” says Dr. Okonkwo. “They’re helpful, but they’re not a substitute for proper Holter monitoring. And we can’t give one to every patient who needs it.”

The gap between guidelines and reality is well documented. A 2024 analysis by the Nuffield Trust, titled “Cardiovascular Disease Prevention: Progress and Challenges,” found that only 60% of patients with a new diagnosis of AF had a documented assessment of stroke risk (CHA₂DS₂-VASc score) within three months, and only half had a bleeding risk assessment. Without these scores, decisions about anticoagulation may be suboptimal. “We’re doing our best,” says Dr. Carter, “but we’re working with limited tools and limited time. AF is a condition that demands a bit more than a ten-minute slot every few months.”

The Cardiologist Bottleneck: Two Referrals, One Slot

The UK has roughly 8.5 cardiologists per 100,000 population, compared with an average of 12 per 100,000 in comparable European countries—for example, Germany has about 12.5 cardiologists per 100,000, France 11.2, and Sweden 9.8. This shortfall is compounded by rising demand: referrals to cardiology have increased by about 30% over the past decade, driven by an aging population and better detection of heart disease. The result is a bottleneck that forces hospitals to triage referrals into urgent and routine categories. AF is often classified as routine unless the patient has symptoms like syncope, heart failure, or a very high ventricular rate. The NHS backlog for cardiology appointments has been exacerbated by the COVID-19 pandemic, which disrupted routine services and diverted resources to urgent care. As of early 2025, the total waiting list for first outpatient appointments in England stood at over 6 million, with cardiology among the specialties with the longest waits. The government has pledged to reduce waiting times, but progress has been slow. A 2024 report by the Health Foundation warned that without additional investment in workforce and infrastructure, waiting times for cardiology are likely to remain above 18 weeks for the foreseeable future.

“Urgent referrals for suspected acute coronary syndrome or heart failure take priority,” says Dr. Sarah Mitchell, a consultant cardiologist at a large NHS trust in the North West. “AF patients are stable in the sense that they’re not going to arrest tomorrow, but they are at risk of stroke and their quality of life is often poor. Yet they end up at the back of the queue.” The routine waiting list for cardiology in her trust exceeds 600 patients, with some waiting more than nine months. “I see patients who have been waiting so long that their AF has become persistent, and they’ve developed complications like left atrial enlargement, which makes ablation more difficult.”

The private sector offers a faster route: a consultation with a cardiologist typically costs between £200 and £300, and private health insurance can cover some of that. But for many patients, especially those on lower incomes or in areas with limited private provision, that is not an option. “I looked into going private,” says Margaret. “But I’m on a state pension. I couldn’t justify spending that much.” The result is a two-tier system where those who can afford to pay skip the queue, while others wait—and wait.

What Happens in the Waiting Months

While patients wait for a cardiologist, primary care manages their AF as best it can. Anticoagulation is usually started promptly, and rate-control drugs like beta-blockers or calcium channel blockers are prescribed. But rhythm control—restoring and maintaining normal sinus rhythm—is generally deferred to the specialist. “We can start a beta-blocker and get the heart rate under 100, but that doesn’t mean the patient feels well,” says Dr. Okonkwo. “Many patients still have symptoms like palpitations, breathlessness, and fatigue. They want to be in normal rhythm, and we can’t offer that in primary care.”

The delay in rhythm control has consequences. AF that is left untreated can become persistent, meaning the heart is in AF all the time. Persistent AF is harder to cardiovert and more likely to recur after ablation. A 2023 study in Heart found that patients who waited more than six months for rhythm control were 40% less likely to maintain sinus rhythm at one year compared with those treated within three months. “The longer you wait, the more the atria remodel,” explains Dr. Mitchell. “The muscle stretches, fibrosis sets in, and the electrical pathways change. Early intervention is key, but we’re not delivering it.”

Patient anxiety and symptom burden are high. A survey by the AF Association found that 70% of patients reported that AF interfered with daily activities, and 45% said they had visited an emergency department at least once while waiting for a specialist appointment. Rapid AF with a ventricular rate over 150 can cause breathlessness, chest pain, and dizziness, prompting a trip to A&E. “I ended up in A&E twice because my heart was racing and I couldn’t breathe,” says Margaret. “Each time they gave me a bolus of beta-blocker, my rate slowed, and they sent me home. But I still didn’t have a cardiology appointment.”

Emergency visits for AF are costly and disruptive. A 2024 analysis by the NHS Confederation estimated that each AF-related A&E attendance costs the health service roughly £150–200, not including the cost of treatment or follow-up. For patients, the experience is stressful and reinforces a sense that their condition is not being taken seriously. “I felt like I was a nuisance,” Margaret says. “But I couldn’t help it. My heart was doing something scary.”

A Faster Path: What the Data Show

Several pilot schemes across the UK have shown that the wait for specialist AF care can be reduced dramatically without increasing costs. One model involves same-day ECG triage in GP hubs, where patients with suspected AF are seen by a practice nurse or GP with a special interest, who performs an ECG and, if AF is confirmed, starts anticoagulation and refers directly to a rapid-access cardiology clinic. A pilot in London reported that such hubs reduced the median time from referral to cardiology appointment from 18 weeks to 4 weeks.

Nurse-led AF clinics have also shown promise. In a study published in the European Journal of Cardiovascular Nursing in 2024, nurse-led clinics in three NHS trusts reduced the wait for a specialist review from 16 weeks to 8 weeks, while maintaining patient satisfaction and clinical outcomes. Nurses performed initial assessments, initiated and monitored anticoagulation, and referred complex cases to cardiologists. “Nurse-led clinics free up consultant time for the patients who really need it,” says Dr. Mitchell. “They’re safe, effective, and patients like them.”

Remote monitoring is another tool that can reduce the need for face-to-face appointments. Implantable loop recorders and wearable devices can transmit ECG data to a monitoring centre, allowing cardiologists to review arrhythmia burden remotely and triage patients who need intervention. A 2025 review by NICE endorsed the use of remote monitoring for AF, noting that it could reduce hospital visits and improve detection of asymptomatic AF. However, uptake has been slow due to funding constraints and the need for staff training.

Direct-access echocardiography—where GPs can refer patients for an echo without a cardiology consultation—is also backed by NICE. This allows primary care to assess left atrial size, valve function, and ventricular function, which inform treatment decisions. A pilot in the West Midlands found that direct-access echo reduced the number of cardiology referrals by 30%, as many patients with normal echoes and well-controlled AF could be managed in primary care. “If we can rule out structural heart disease, we can often manage AF in the community,” says Dr. Carter. “But we need the tools to do that.”

A Counter-Argument: Not All AF Patients Need a Cardiologist

It is important to acknowledge that not every patient with AF requires an urgent cardiologist review. For many, particularly those with low symptom burden and well-controlled rate, primary care management with anticoagulation and rate control is sufficient. The NICE guidelines suggest that rhythm control should be considered for patients who remain symptomatic despite rate control, or for those who prefer it. A 2023 analysis from the University of Oxford found that up to 40% of AF patients in primary care could be managed without specialist input, provided that GPs have access to appropriate diagnostic tools and support. “We need to avoid over-referring,” says Dr. Carter. “Some patients are happy with rate control and don’t want an ablation. But the decision should be shared, and that requires a discussion that a GP can facilitate if they have the confidence and the time.”

However, the counter-argument also highlights a risk: if community services are expanded without adequate training and resources, there is a danger that patients who do need specialist care will be missed. “We can’t just push everything into primary care without giving GPs the tools and the backup,” says Dr. Mitchell. “You need a clear pathway for escalation when things don’t go as planned.” A pilot in the South West found that when GPs were given direct-access to echocardiography and ambulatory monitoring, referrals to cardiology initially dropped, but then rebounded as GPs identified more patients with structural heart disease who truly needed a specialist. The net effect was a more appropriate use of resources, but it required investment in training and equipment.

Three Changes That Could Halve the Wait

First, standardised referral criteria for AF could ensure that patients are triaged appropriately and that only those who need specialist input are referred. Many GPs refer all AF patients to cardiology because they lack confidence in managing the condition alone. Clear criteria—based on age, comorbidities, symptoms, and CHA₂DS₂-VASc score—could help GPs decide who truly needs a cardiologist and who can be managed in primary care with nurse-led support. The 2024 consensus statement from the British Cardiovascular Society, titled “Referral Criteria for Atrial Fibrillation in Primary Care,” outlined such criteria, but adoption has been patchy. The statement recommends that patients with symptomatic AF, failed rate control, or complex comorbidities (e.g., heart failure, valvular disease) should be referred, while those with asymptomatic, well-controlled AF can be managed in the community.

Second, a GP-specialist digital advice platform—like the “advice and guidance” service already used in some NHS regions—could allow GPs to send a clinical query to a cardiologist without making a formal referral. The cardiologist reviews the ECG and history and responds within a few days, offering management advice or agreeing that a referral is needed. A study in the British Journal of Cardiology in 2023 found that such platforms avoided a face-to-face appointment in about 40% of cases, reducing waiting times for both the patients who avoided referral and those who genuinely needed one. This approach differs from standardised referral criteria in that it provides individualised, case-based advice, rather than a one-size-fits-all rule. “The advice and guidance platform allows for nuance,” says Dr. Okonkwo. “I can send a trace and say, ‘This patient has AF with a rate of 110, but they’re asymptomatic – do they need rhythm control?’ The cardiologist can answer without seeing them.”

Third, community cardiology outreach—where cardiologists hold clinics in GP surgeries or community hospitals—could bring specialist care closer to patients and reduce the demand on hospital outpatient departments. A pilot in Nottinghamshire found that community cardiology clinics reduced the median wait from 14 weeks to 6 weeks, and patients reported higher satisfaction. “It’s about meeting patients where they are,” says Dr. Mitchell. “We need to shift the model from hospital-centric to community-based. That requires investment, but it pays off in reduced waits and better outcomes.”

Political will and funding are the missing ingredients. The NHS long-term plan includes commitments to expand community diagnostics and reduce waiting times, but implementation has been uneven. Without a sustained focus on AF—a condition that affects millions and costs the NHS an estimated £2 billion per year in stroke-related care—the six-month wait will persist. For patients like Margaret, who finally saw a cardiologist after seven months and was offered an ablation, the wait was too long. “I had the ablation three weeks ago, and I feel like a different person,” she says. “But I wonder how many people are still waiting.”